International Biotechnology Trust plc (IBT) — Net Asset Quality Index
International Biotechnology Trust plc (IBT) has a Net Asset Quality Index of 87.8% as of August 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of GBX284.04 Million minus total liabilities of GBX34.63 Million yields net assets of GBX249.41 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check IBT financial resilience to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
International Biotechnology Trust plc Net Asset Quality Index Over Time (2000–2025)
This chart shows how International Biotechnology Trust plc's Net Asset Quality Index has evolved across 26 annual periods from 2000 to 2025. As of August 2025, the index stands at 87.8%, representing net assets of GBX249.41 Million against total assets of GBX284.04 Million GBX. See working capital to net assets of International Biotechnology Trust plc to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for International Biotechnology Trust plc (2000–2025)
The table below presents the year-by-year Net Asset Quality Index for International Biotechnology Trust plc from 2000 to 2025, covering 26 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see market value of International Biotechnology Trust plc.
| Year | Quality Index | Net Assets (GBX) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 87.8% | GBX249.41 Million | GBX284.04 Million | GBX34.63 Million | ▼ -3.8 pp |
| 2024 | 91.6% | GBX282.26 Million | GBX308.15 Million | GBX25.89 Million | ▲ +2.9 pp |
| 2023 | 88.7% | GBX270.32 Million | GBX304.87 Million | GBX34.55 Million | ▲ +1.5 pp |
| 2022 | 87.1% | GBX284.89 Million | GBX326.92 Million | GBX42.03 Million | ▼ -5.9 pp |
| 2021 | 93.1% | GBX323.77 Million | GBX347.83 Million | GBX24.06 Million | ▼ -0.7 pp |
| 2020 | 93.8% | GBX283.90 Million | GBX302.71 Million | GBX18.81 Million | ▼ -6.2 pp |
| 2019 | 100.0% | GBX240.82 Million | GBX240.86 Million | GBX42.00K | ▲ +0.3 pp |
| 2018 | 99.7% | GBX262.47 Million | GBX263.22 Million | GBX744.00K | ▲ +6.9 pp |
| 2017 | 92.8% | GBX252.65 Million | GBX272.34 Million | GBX19.69 Million | ▼ -1.0 pp |
| 2016 | 93.7% | GBX216.65 Million | GBX231.12 Million | GBX14.47 Million | ▲ +3.6 pp |
| 2015 | 90.2% | GBX236.00 Million | GBX261.68 Million | GBX25.68 Million | ▼ -5.1 pp |
| 2014 | 95.3% | GBX214.97 Million | GBX225.61 Million | GBX10.64 Million | ▼ -4.6 pp |
| 2013 | 99.9% | GBX172.67 Million | GBX172.90 Million | GBX224.00K | ▲ +0.0 pp |
| 2012 | 99.8% | GBX128.92 Million | GBX129.12 Million | GBX199.00K | ▲ +9.3 pp |
| 2011 | 90.6% | GBX91.76 Million | GBX101.32 Million | GBX9.55 Million | ▼ -7.9 pp |
| 2010 | 98.5% | GBX93.66 Million | GBX95.07 Million | GBX1.41 Million | ▼ -1.0 pp |
| 2009 | 99.5% | GBX98.25 Million | GBX98.72 Million | GBX464.00K | ▲ +0.5 pp |
| 2008 | 99.0% | GBX113.52 Million | GBX114.69 Million | GBX1.17 Million | ▲ +0.7 pp |
| 2007 | 98.3% | GBX102.36 Million | GBX104.11 Million | GBX1.75 Million | ▼ -1.4 pp |
| 2006 | 99.8% | GBX66.95 Million | GBX67.12 Million | GBX167.00K | ▲ +1.0 pp |
| 2005 | 98.8% | GBX58.00 Million | GBX58.73 Million | GBX731.00K | ▼ -0.6 pp |
| 2004 | 99.3% | GBX55.15 Million | GBX55.53 Million | GBX378.00K | ▲ +0.1 pp |
| 2003 | 99.2% | GBX53.93 Million | GBX54.34 Million | GBX410.00K | ▲ +0.6 pp |
| 2002 | 98.7% | GBX47.90 Million | GBX48.54 Million | GBX643.00K | ▲ +0.5 pp |
| 2001 | 98.2% | GBX98.74 Million | GBX100.58 Million | GBX1.84 Million | ▲ +2.8 pp |
| 2000 | 95.4% | GBX349.33 Million | GBX366.17 Million | GBX16.84 Million | — |